Background: Toxoplasma gondii is a pathogen implicated in psychiatric disorders. As elevated antibodies to T. gondii are also present in non-symptomatic individuals, we hypothesized that the age during first exposure to the pathogen may affect symptom manifestation. We tested this hypothesis by evaluating neurobehavioral abnormalities and the immune response in mice following adolescent or adult T. gondii infection. Methods: Mice were infected with T. gondii at postnatal day 33 (adolescent/juvenile) or 61 (adult). At 8 weeks post-infection (wpi), pre-pulse inhibition of the acoustic startle (PPI) in mice administered MK-801 (0.1 and 0.3 mg/kg) and amphetamine (5 and 10 mg/kg) was assessed. Peripheral (anti-T. gondii, C1q-associated IgG and anti-GLUN2 antibodies) and central (C1q and Iba1) markers of the immune response were also evaluated. In addition, regional brain expression of N-methyl-D-aspartate receptor (NMDAR) subunits (GLUN1 and GLUN2A), glutamatergic (vGLUT1, PSD95) and GABAergic (GAD67) markers, and monoamines (DA, NE, 5-HT) and their metabolites were measured. Results: Juvenile and adult infected mice exhibited opposite effects of MK-801 on PPI, with decreased PPI in juveniles and increased PPI in adults. There was a significantly greater elevation of GLUN2 autoantibodies in juvenilecompared to adult-infected mice. In addition, age-dependent differences were found in regional expression of NMDAR subunits and markers of glutamatergic, GABAergic, and monoaminergic systems. Activated microglia and C1q elevations were found in both juvenile-and adult-T. gondii infected mice. Conclusions: Our study demonstrates that the age at first exposure to T. gondii is an important factor in shaping distinct behavioral and neurobiological abnormalities. Elevation in GLUN2 autoantibodies or complement protein C1q may be a potential underlying mechanism. A better understanding of these age-related differences may lead to more efficient treatments of behavioral disorders associated with T. gondii infection.
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Introduction
Psychiatric disorders such as schizophrenia are etiologically complex and likely arise from a combination of genetic and environmental contributions throughout life. One environmental factor that has been implicated in psychiatric disorders is pathogen exposure (Yolken and Torrey, 2008) . Infection with the protozoan parasite Toxoplasma gondii (T. gondii) is suggested to increase the risk of developing schizophrenia, bipolar disorder, or other alterations in human behavior (Flegr, 2007; Hamidinejat et al., 2010; Hodkova et al., 2007; Torrey et al., 2012; Torrey et al., 2007; Wang et al., 2006) . The association of T. gondii infection and abnormal human behavior has come out of serological studies looking at T. gondii-specific antibodies. Elevated anti-T. gondii antibodies are detected in a greater percentage of psychiatric patients than control subjects, indicating there are individuals that have antibodies to T. gondii but do not exhibit clinical symptoms (Torrey et al., 2007) . Abnormal behavior in only a subset of infected individuals may be partly explained by the age at which an individual is first exposed to T. gondii. Indeed, environmental stressors during critical periods of
